Showing results (21-30 of 65) with videos related to

Sort By:
Pageof 7
Microorganisms|March 27, 2025
In Infants with Neuroblastoma Standard Therapy Only Partially Reverts the Fecal Microbiome Dysbiosis Present at DiagnosisMaria Valeria Corrias, Eddi Di Marco, Carola Bonaretti, et al.
Cellular Oncology : the Official Journal of the International Society for Cellular Oncology|March 9, 2010
Different subcellular localization of ALCAM molecules in neuroblastoma: Association with relapseMaria Valeria Corrias, Claudio Gambini, Andrea Gregorio, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 12, 2013
Neuroblastoma-derived TGF-β1 modulates the chemokine receptor repertoire of human resting NK cellsRoberta Castriconi, Alessandra Dondero, Francesca Bellora, et al.
Scientific Reports|October 27, 2017
Combined immunotherapy with anti-PDL-1/PD-1 and anti-CD4 antibodies cures syngeneic disseminated neuroblastomaValentina Rigo, Laura Emionite, Antonio Daga, et al.
Annals of the New York Academy of Sciences|January 15, 2005
Immunogenicity of human neuroblastomaIgnazia Prigione, Maria Valeria Corrias, Irma Airoldi, et al.
International Journal of Cancer|December 30, 2009
Transient depletion of CD4(+) T cells augments IL-21-based immunotherapy of disseminated neuroblastoma in syngeneic miceMichela Croce, Maria Valeria Corrias, Anna Maria Orengo, et al.
Cancer Immunology, Immunotherapy : CII|March 21, 2014
Recombinant IL-21 and anti-CD4 antibodies cooperate in syngeneic neuroblastoma immunotherapy and mediate long-lasting immunityValentina Rigo, Maria Valeria Corrias, Anna Maria Orengo, et al.
Bone|July 7, 2010
Neuroblastoma and bone metastases: clinical significance and prognostic value of Dickkopf 1 plasma levelsDonatella Granchi, Maria Valeria Corrias, Alberto Garaventa, et al.
Journal of Immunology Research|May 12, 2015
IL-10 and ARG-1 concentrations in bone marrow and peripheral blood of metastatic neuroblastoma patients do not associate with clinical outcomeFabio Morandi, Michela Croce, Giuliana Cangemi, et al.
Cancer Immunology, Immunotherapy : CII|February 21, 2003
Expression of HER2/neu is uncommon in human neuroblastic tumors and is unrelated to tumor progressionClaudio Gambini, Angela Rita Sementa, Luca Boni, et al.
Pageof 7